MedPath

BIO|CONCEPT.ECG-Library (Collection of ECG Signals for Development of Algorithms)

Not Applicable
Terminated
Conditions
Rhythm; Abnormal
Heart Diseases
Interventions
Diagnostic Test: 3-channel Holter ECG recording
Diagnostic Test: 12-channel Holter ECG recording
Registration Number
NCT04243070
Lead Sponsor
Biotronik SE & Co. KG
Brief Summary

Collection of Holter surface ECGs for the development of new sensing and detection algorithms

Detailed Description

The aim of the study is to collect data from surface ECGs by using Holter ECG recordings from patients with different forms of diagnosed arrhythmias and/or specific ECG characteristics from heart diseases to support the development of new sensing and detection algorithms for implants.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
89
Inclusion Criteria
  • Patient is able to understand the nature of the study and willing to provide written informed consent.
  • Patient is willing and able to attend Holter ECG procedure following a visit
  • History of at least one of the following conditions (established via ECG prior to enrollment):

(A) Patient with pacemaker/ICD and

  1. Ventricular stimulation > 30 % or

    (B) Patient either without pacemaker/ICD or with pacemaker/ICD, but without significant atrial and ventricular stimulation and at least one of the following:

  2. Frequent Ventricular Extrasystoles (VES) (incl. Bigeminus) or

  3. Atrioventricular Reentrant Tachycardia (AVRT)/Wolff-Parkinson-White (WPW) syndrome or

  4. Atrioventricular Nodal Reentrant Tachycardia (AVNRT) or

  5. Sinus Tachycardia at rest or

  6. Atrial Flutter or

  7. Any form of Ventricular Tachycardia (VT) or

  8. Silent/Paroxysmal/persistent/permanent AF or

  9. Brugada syndrome or

  10. Long QT syndrome or

  11. Right Bundle Branch Block (RBBB) or

  12. Left Bundle Branch Block (LBBB) or

  13. Myocardial Ischemia/Acute Myocardial Infarction or

  14. Other abnormal QRS(T) complex, ST segment or T-wave morphology, i.e. any other QRS anomaly / ST segment elevation / ST segment Depression / T wave changes

Exclusion Criteria
  • Any condition which precludes the patient's ability to comply with the study requirements.
  • Known allergy to patch electrodes.
  • Pregnant or breast feeding.
  • Less than 18 years old.
  • Participation in another interventional clinical investigation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
3-channel Holter ECG recording for EPS patient3-channel Holter ECG recordingPatients participating in an EPS will undergo a 3-channel Holter ECG recording in parallel to the standard 12-channel Holter ECG recording during the EPS followed by an optional 24 h observation period
12-channel Holter ECG recording for non-EPS patients12-channel Holter ECG recordingPatients scheduled for a follow-up for their heart disease will undergo a 12-channel Holter ECG recording while participating in a Body Motion test followed by a 24 h observation period
Primary Outcome Measures
NameTimeMethod
Number of Successful ECG Recordings Per Condition24 hours

All ECG recordings were evaluated by an internal board and all patients were allocated to one of 15 groups (covering 14 ECG patterns of interest and one group for "no ECG pattern of interest recorded").

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (5)

Vivantes-Krankenhaus im Friedrichshain

🇩🇪

Berlin, Germany

Universitätsklinikum Gießen und Marburg GmbH (UKGM)

🇩🇪

Gießen, Germany

Otto-von-Guericke-Universität Magdeburg

🇩🇪

Magdeburg, Germany

Universitätsklinikum Gießen und Marburg GmbH

🇩🇪

Marburg, Germany

Universitätsklinikum Erlangen

🇩🇪

Erlangen, Germany

© Copyright 2025. All Rights Reserved by MedPath